Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival - PubMed (original) (raw)
Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival
Lucia Mincheva-Nilsson et al. J Immunol. 2006.
Abstract
Mammalian pregnancy is an intriguing immunological phenomenon where the semiallogeneic fetus is not rejected. Tolerance toward the fetus involves a number of mechanisms associated with modifications of the immune status of the mother. In this study, we strongly suggest a novel mechanism for fetal evasion of maternal immune attack, based on the engagement and down-regulation of the activating NK cell receptor NKG2D on PBMC by soluble MHC class I chain-related proteins A and B (collectively termed MIC). A similar immune escape pathway was previously described in tumors. We found that MIC mRNA was constitutively expressed by human placenta and could be up-regulated upon heat shock treatment. Our immunomorphologic studies showed that the MIC expression in placenta was restricted to the syncytiotrophoblast. Immunoelectron microscopy revealed a dual MIC expression in the syncytiotrophoblast: on the apical and basal cell membrane and in cytoplasmic vacuoles as MIC-loaded microvesicles/exosomes. Soluble MIC molecules were present at elevated levels in maternal blood throughout normal pregnancy and were released by placental explants in vitro. Simultaneously, the cell surface NKG2D expression on maternal PBMC was down-regulated compared with nonpregnant controls. The soluble MIC molecules in pregnancy serum were able to interact with NKG2D and down-regulate the receptor on PBMC from healthy donors, with the consequent inhibition of the NKG2D-dependent cytotoxic response. These findings suggest a new physiological mechanism of silencing the maternal immune system that promotes fetal allograft immune escape and supports the view of the placenta as an immunoregulatory organ.
Similar articles
- Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.
Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L. Hedlund M, et al. J Immunol. 2009 Jul 1;183(1):340-51. doi: 10.4049/jimmunol.0803477. J Immunol. 2009. PMID: 19542445 - Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM. Doubrovina ES, et al. J Immunol. 2003 Dec 15;171(12):6891-9. doi: 10.4049/jimmunol.171.12.6891. J Immunol. 2003. PMID: 14662896 - Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H, Kim J, Cosman D, Choi I. Song H, et al. Cell Immunol. 2006 Jan;239(1):22-30. doi: 10.1016/j.cellimm.2006.03.002. Epub 2006 Apr 21. Cell Immunol. 2006. PMID: 16630603 - Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D. Chitadze G, et al. Scand J Immunol. 2013 Aug;78(2):120-9. doi: 10.1111/sji.12072. Scand J Immunol. 2013. PMID: 23679194 Review. - HLA-G and immune tolerance in pregnancy.
Hunt JS, Petroff MG, McIntire RH, Ober C. Hunt JS, et al. FASEB J. 2005 May;19(7):681-93. doi: 10.1096/fj.04-2078rev. FASEB J. 2005. PMID: 15857883 Review.
Cited by
- Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity.
Labani-Motlagh A, Israelsson P, Ottander U, Lundin E, Nagaev I, Nagaeva O, Dehlin E, Baranov V, Mincheva-Nilsson L. Labani-Motlagh A, et al. Tumour Biol. 2016 Apr;37(4):5455-66. doi: 10.1007/s13277-015-4313-2. Epub 2015 Nov 13. Tumour Biol. 2016. PMID: 26563374 - NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications.
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K. Siemaszko J, et al. Cells. 2021 Jun 7;10(6):1420. doi: 10.3390/cells10061420. Cells. 2021. PMID: 34200375 Free PMC article. Review. - Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis.
Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M, Rice GE. Salomon C, et al. PLoS One. 2013 Jul 8;8(7):e68451. doi: 10.1371/journal.pone.0068451. Print 2013. PLoS One. 2013. PMID: 23861904 Free PMC article. - The NKG2D receptor: immunobiology and clinical implications.
Burgess SJ, Maasho K, Masilamani M, Narayanan S, Borrego F, Coligan JE. Burgess SJ, et al. Immunol Res. 2008;40(1):18-34. doi: 10.1007/s12026-007-0060-9. Immunol Res. 2008. PMID: 18193361 Review. - Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study.
Kirsten H, Petit-Teixeira E, Scholz M, Hasenclever D, Hantmann H, Heider D, Wagner U, Sack U, Hugo Teixeira V, Prum B, Burkhardt J, Pierlot C, Emmrich F, Cornelis F, Ahnert P. Kirsten H, et al. Arthritis Res Ther. 2009;11(3):R60. doi: 10.1186/ar2683. Epub 2009 May 1. Arthritis Res Ther. 2009. PMID: 19409079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials